Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma
Thistlethwaite , FC, Elkord, E, Griffiths, RW, Burt, DJ, Shablak, AM, Campbell, JDM, Gilham, DE, Austin, EB, Stern, PL and Hawkins, RE 2008, 'Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma ' , Cancer Immunology, Immunotherapy, 57 (5) , pp. 623-634.
|PDF - Published Version |
Restricted to Repository staff only
Download (589kB) | Request a copy
PURPOSE: CD4(+)CD25(+) regulatory T (T(reg)) cells are present in increased numbers in patients with advanced cancer and CD25(+) T cell depletion potentiates tumour immunity in animal models. The aim of this study was to assess the feasibility and safety of adoptive transfer of CD25(+) depleted autologous T cells in patients with advanced renal cell carcinoma and to examine resulting changes in lymphocyte subsets. PATIENTS AND METHODS: Six patients with advanced renal cell carcinoma underwent leukapheresis followed by conditioning chemotherapy with cyclophosphamide and fludarabine. The autologous leukapheresis product was depleted of CD25(+) cells using CliniMACS System then re-infused into the patient. RESULTS: Efficient CD25(+) depletion from all leukapheresis products was achieved and 0.55-5.87 x 10(7)/kg CD3(+) cells were re-infused. Chemotherapy related haematological toxicity was observed, but blood counts recovered in all patients allowing discharge after a mean inpatient stay of 21 days. One patient subsequently developed a rapidly progressive neurological syndrome. A transient reduction in CD25(+) subset was noted in the peripheral blood of 5 out of 6 patients with evidence of increased T cell responses to PHA in 4 out of 6 patients. One patient showed increased specific proliferative responses to the tumour associated antigen h5T4 coinciding with the nadir of T(reg) cells. CONCLUSIONS: Given the transient nature of the reduction in CD25(+) subset and the observed toxicity there is a need to explore further strategies to improve the safety and efficacy of this approach. Nevertheless, the results provide proof of concept in potentiation of tumour antigen T cell responses when T(reg) cell levels are depleted.
|Themes:||Health and Wellbeing|
|Schools:||Colleges and Schools > College of Science & Technology > School of Environment and Life Sciences > Biomedical Research Centre|
Colleges and Schools > College of Science & Technology > School of Environment and Life Sciences
|Journal or Publication Title:||Cancer Immunology, Immunotherapy|
|Depositing User:||E Elkord|
|Date Deposited:||13 Oct 2011 10:36|
|Last Modified:||20 Aug 2013 18:13|
Actions (login required)
|Edit record (repository staff only)|